zidovudine

Key facts

INN

zidovudine

Brand

ZIDOVUDINE

Route

INJECTION

Formulation

CAPSULE

Originator

Regen BioPharma Inc

Related patents

patent

US 12404505

Delivery of a gene-editing system with a single retroviral particle and methods

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12280063

Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11814641

Retroviral and lentiviral vectors

Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11744831

Antiviral JAK inhibitors useful in treating or preventing retroviral and other v

Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11591613

Retroviral and lentiviral vectors

Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11135283

Retroviral vector for the administration and expression of replicon RNA expressi

Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11065254

Antiviral JAK inhibitors useful in treating or preventing retroviral and other v

Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10954530

Retroviral and lentiviral vectors

Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is zidovudine?

zidovudine (ZIDOVUDINE), is a pharmaceutical active ingredient, associated with Regen BioPharma Inc, with approved status in the US.

What is the brand name for zidovudine?

ZIDOVUDINE is a marketed brand name for zidovudine. Check FDA Drugs@FDA for the current US label holder.